Project
Illumina Body Map 2
Navigation
Downloads
Results for NR1I2
Z-value: 1.14
Motif logo
Transcription factors associated with NR1I2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NR1I2
|
ENSG00000144852.12 | nuclear receptor subfamily 1 group I member 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NR1I2 | hg19_v2_chr3_+_119501557_119501557 | 0.22 | 2.2e-01 | Click! |
Activity profile of NR1I2 motif
Sorted Z-values of NR1I2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr12_-_91576429 | 5.42 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
| chr20_+_43343886 | 3.70 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr15_+_96875657 | 3.46 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr15_+_96876340 | 3.19 |
ENST00000453270.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr7_-_27169801 | 3.16 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
| chr1_-_173886491 | 2.82 |
ENST00000367698.3
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
| chr6_-_75912508 | 2.79 |
ENST00000416123.2
|
COL12A1
|
collagen, type XII, alpha 1 |
| chr1_-_178840157 | 2.72 |
ENST00000367629.1
ENST00000234816.2 |
ANGPTL1
|
angiopoietin-like 1 |
| chr3_-_49722523 | 2.67 |
ENST00000448220.1
|
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
| chr8_-_82395461 | 2.67 |
ENST00000256104.4
|
FABP4
|
fatty acid binding protein 4, adipocyte |
| chr1_+_201979743 | 2.65 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr1_+_201979645 | 2.57 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr8_+_99956662 | 2.49 |
ENST00000523368.1
ENST00000297565.4 ENST00000435298.2 |
OSR2
|
odd-skipped related transciption factor 2 |
| chr7_+_134576151 | 2.43 |
ENST00000393118.2
|
CALD1
|
caldesmon 1 |
| chr15_-_65067773 | 2.39 |
ENST00000300069.4
|
RBPMS2
|
RNA binding protein with multiple splicing 2 |
| chr9_-_129885010 | 2.37 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
| chr1_+_199996733 | 2.32 |
ENST00000236914.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
| chr12_-_91576561 | 2.28 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
| chr9_-_129884902 | 2.28 |
ENST00000373417.1
|
ANGPTL2
|
angiopoietin-like 2 |
| chr11_+_117073850 | 2.22 |
ENST00000529622.1
|
TAGLN
|
transgelin |
| chr3_+_112930306 | 2.22 |
ENST00000495514.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
| chr17_-_34345002 | 2.20 |
ENST00000293280.2
|
CCL23
|
chemokine (C-C motif) ligand 23 |
| chr17_-_46682321 | 2.19 |
ENST00000225648.3
ENST00000484302.2 |
HOXB6
|
homeobox B6 |
| chr12_-_91576750 | 2.17 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
| chr13_-_110959478 | 2.15 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
| chr1_+_199996702 | 2.15 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
| chr1_+_200011711 | 2.13 |
ENST00000544748.1
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
| chr1_+_16083154 | 2.11 |
ENST00000375771.1
|
FBLIM1
|
filamin binding LIM protein 1 |
| chr4_-_110723134 | 2.10 |
ENST00000510800.1
ENST00000512148.1 |
CFI
|
complement factor I |
| chr9_-_14313893 | 2.09 |
ENST00000380921.3
ENST00000380959.3 |
NFIB
|
nuclear factor I/B |
| chr4_-_110723335 | 2.05 |
ENST00000394634.2
|
CFI
|
complement factor I |
| chr1_+_16083098 | 2.03 |
ENST00000496928.2
ENST00000508310.1 |
FBLIM1
|
filamin binding LIM protein 1 |
| chr4_-_110723194 | 2.03 |
ENST00000394635.3
|
CFI
|
complement factor I |
| chr1_+_22970119 | 2.03 |
ENST00000374640.4
ENST00000374639.3 ENST00000374637.1 |
C1QC
|
complement component 1, q subcomponent, C chain |
| chr17_-_34344991 | 2.02 |
ENST00000591423.1
|
CCL23
|
chemokine (C-C motif) ligand 23 |
| chr1_+_16083123 | 2.00 |
ENST00000510393.1
ENST00000430076.1 |
FBLIM1
|
filamin binding LIM protein 1 |
| chr8_+_11561660 | 1.96 |
ENST00000526716.1
ENST00000335135.4 ENST00000528027.1 |
GATA4
|
GATA binding protein 4 |
| chr11_+_69831982 | 1.92 |
ENST00000534086.1
|
RP11-626H12.1
|
RP11-626H12.1 |
| chr8_+_99956759 | 1.90 |
ENST00000522510.1
ENST00000457907.2 |
OSR2
|
odd-skipped related transciption factor 2 |
| chr10_+_24755416 | 1.88 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
| chr12_-_96184533 | 1.87 |
ENST00000343702.4
ENST00000344911.4 |
NTN4
|
netrin 4 |
| chr1_+_82165350 | 1.83 |
ENST00000359929.3
|
LPHN2
|
latrophilin 2 |
| chr7_-_107642348 | 1.82 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
| chr22_+_21128167 | 1.82 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
| chr3_+_12330560 | 1.81 |
ENST00000397026.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
| chr12_+_52626898 | 1.80 |
ENST00000331817.5
|
KRT7
|
keratin 7 |
| chr1_+_145413268 | 1.80 |
ENST00000421822.2
ENST00000336751.5 ENST00000497365.1 ENST00000475797.1 |
HFE2
|
hemochromatosis type 2 (juvenile) |
| chr10_-_33625154 | 1.79 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
| chr12_-_96184913 | 1.77 |
ENST00000538383.1
|
NTN4
|
netrin 4 |
| chr1_-_12679171 | 1.75 |
ENST00000606790.1
|
RP11-474O21.5
|
RP11-474O21.5 |
| chrX_+_99839799 | 1.75 |
ENST00000373031.4
|
TNMD
|
tenomodulin |
| chr2_-_75426183 | 1.74 |
ENST00000409848.3
|
TACR1
|
tachykinin receptor 1 |
| chr3_+_112930387 | 1.73 |
ENST00000485230.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
| chr9_-_14313641 | 1.73 |
ENST00000380953.1
|
NFIB
|
nuclear factor I/B |
| chr6_-_154751629 | 1.70 |
ENST00000424998.1
|
CNKSR3
|
CNKSR family member 3 |
| chr2_+_192141611 | 1.69 |
ENST00000392316.1
|
MYO1B
|
myosin IB |
| chr5_-_33892204 | 1.69 |
ENST00000504830.1
|
ADAMTS12
|
ADAM metallopeptidase with thrombospondin type 1 motif, 12 |
| chr1_+_159557607 | 1.67 |
ENST00000255040.2
|
APCS
|
amyloid P component, serum |
| chr1_+_196788887 | 1.67 |
ENST00000320493.5
ENST00000367424.4 ENST00000367421.3 |
CFHR1
CFHR2
|
complement factor H-related 1 complement factor H-related 2 |
| chr6_+_142623063 | 1.66 |
ENST00000296932.8
ENST00000367609.3 |
GPR126
|
G protein-coupled receptor 126 |
| chr2_+_234621551 | 1.65 |
ENST00000608381.1
ENST00000373414.3 |
UGT1A1
UGT1A5
|
UDP glucuronosyltransferase 1 family, polypeptide A8 UDP glucuronosyltransferase 1 family, polypeptide A5 |
| chr3_-_58196688 | 1.65 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr9_-_14314066 | 1.63 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
| chr6_+_142622991 | 1.63 |
ENST00000230173.6
ENST00000367608.2 |
GPR126
|
G protein-coupled receptor 126 |
| chr1_+_207277632 | 1.62 |
ENST00000421786.1
|
C4BPA
|
complement component 4 binding protein, alpha |
| chr4_+_124317940 | 1.62 |
ENST00000505319.1
ENST00000339241.1 |
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
| chr12_-_86230315 | 1.60 |
ENST00000361228.3
|
RASSF9
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 |
| chr9_+_135457530 | 1.59 |
ENST00000263610.2
|
BARHL1
|
BarH-like homeobox 1 |
| chr2_+_234627424 | 1.57 |
ENST00000373409.3
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4 |
| chr1_+_22962948 | 1.57 |
ENST00000374642.3
|
C1QA
|
complement component 1, q subcomponent, A chain |
| chr17_-_7167279 | 1.56 |
ENST00000571932.2
|
CLDN7
|
claudin 7 |
| chr3_+_112929850 | 1.55 |
ENST00000464546.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
| chr5_+_73109339 | 1.55 |
ENST00000296799.4
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28 |
| chr16_+_71392616 | 1.55 |
ENST00000349553.5
ENST00000302628.4 ENST00000562305.1 |
CALB2
|
calbindin 2 |
| chr2_-_105030466 | 1.55 |
ENST00000449772.1
|
AC068535.3
|
AC068535.3 |
| chr1_-_154458520 | 1.53 |
ENST00000486773.1
|
SHE
|
Src homology 2 domain containing E |
| chr2_+_223916862 | 1.53 |
ENST00000604125.1
|
KCNE4
|
potassium voltage-gated channel, Isk-related family, member 4 |
| chr17_-_74528128 | 1.53 |
ENST00000590175.1
|
CYGB
|
cytoglobin |
| chr4_-_70361579 | 1.52 |
ENST00000512583.1
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr17_-_46035187 | 1.51 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
| chr7_-_99381884 | 1.50 |
ENST00000336411.2
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
| chr10_-_131762105 | 1.50 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
| chr2_+_69240302 | 1.50 |
ENST00000303714.4
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr5_+_92919043 | 1.49 |
ENST00000327111.3
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1 |
| chr6_+_12007963 | 1.49 |
ENST00000607445.1
|
RP11-456H18.2
|
RP11-456H18.2 |
| chr3_-_58196939 | 1.49 |
ENST00000394549.2
ENST00000461914.3 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr3_+_193853927 | 1.46 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
| chr15_-_75017711 | 1.46 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr1_+_196912902 | 1.45 |
ENST00000476712.2
ENST00000367415.5 |
CFHR2
|
complement factor H-related 2 |
| chr10_-_74714533 | 1.44 |
ENST00000373032.3
|
PLA2G12B
|
phospholipase A2, group XIIB |
| chr15_+_65337708 | 1.43 |
ENST00000334287.2
|
SLC51B
|
solute carrier family 51, beta subunit |
| chr6_+_152128371 | 1.42 |
ENST00000443427.1
|
ESR1
|
estrogen receptor 1 |
| chr3_+_8543533 | 1.40 |
ENST00000454244.1
|
LMCD1
|
LIM and cysteine-rich domains 1 |
| chr22_-_24641027 | 1.40 |
ENST00000398292.3
ENST00000263112.7 ENST00000418439.2 ENST00000424217.1 ENST00000327365.4 |
GGT5
|
gamma-glutamyltransferase 5 |
| chr8_+_102504651 | 1.40 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr1_+_223101757 | 1.39 |
ENST00000284476.6
|
DISP1
|
dispatched homolog 1 (Drosophila) |
| chr1_+_196743912 | 1.38 |
ENST00000367425.4
|
CFHR3
|
complement factor H-related 3 |
| chr6_-_85474219 | 1.37 |
ENST00000369663.5
|
TBX18
|
T-box 18 |
| chr12_-_56106060 | 1.35 |
ENST00000452168.2
|
ITGA7
|
integrin, alpha 7 |
| chr2_+_69240511 | 1.35 |
ENST00000409349.3
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr19_+_4153598 | 1.34 |
ENST00000078445.2
ENST00000252587.3 ENST00000595923.1 ENST00000602257.1 ENST00000602147.1 |
CREB3L3
|
cAMP responsive element binding protein 3-like 3 |
| chr8_+_102504979 | 1.34 |
ENST00000395927.1
|
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr3_+_111630451 | 1.33 |
ENST00000495180.1
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
| chr16_-_15950868 | 1.33 |
ENST00000396324.3
ENST00000452625.2 ENST00000576790.2 ENST00000300036.5 |
MYH11
|
myosin, heavy chain 11, smooth muscle |
| chr6_+_43738444 | 1.32 |
ENST00000324450.6
ENST00000417285.2 ENST00000413642.3 ENST00000372055.4 ENST00000482630.2 ENST00000425836.2 ENST00000372064.4 ENST00000372077.4 ENST00000519767.1 |
VEGFA
|
vascular endothelial growth factor A |
| chr13_-_28896641 | 1.32 |
ENST00000543394.1
|
FLT1
|
fms-related tyrosine kinase 1 |
| chr2_+_69240415 | 1.32 |
ENST00000409829.3
|
ANTXR1
|
anthrax toxin receptor 1 |
| chr7_-_22259845 | 1.29 |
ENST00000420196.1
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr1_+_207277590 | 1.29 |
ENST00000367070.3
|
C4BPA
|
complement component 4 binding protein, alpha |
| chr8_-_13372395 | 1.28 |
ENST00000276297.4
ENST00000511869.1 |
DLC1
|
deleted in liver cancer 1 |
| chr6_+_152128686 | 1.27 |
ENST00000206249.3
|
ESR1
|
estrogen receptor 1 |
| chr1_+_196743943 | 1.23 |
ENST00000471440.2
ENST00000391985.3 |
CFHR3
|
complement factor H-related 3 |
| chr9_+_133305669 | 1.23 |
ENST00000302481.1
|
HMCN2
|
hemicentin 2 |
| chr15_+_101420028 | 1.22 |
ENST00000557963.1
ENST00000346623.6 |
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3 |
| chr3_+_112930373 | 1.22 |
ENST00000498710.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
| chr2_+_177015950 | 1.21 |
ENST00000306324.3
|
HOXD4
|
homeobox D4 |
| chr6_+_12007897 | 1.19 |
ENST00000437559.1
|
RP11-456H18.2
|
RP11-456H18.2 |
| chr5_+_78985673 | 1.19 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr4_+_77356248 | 1.18 |
ENST00000296043.6
|
SHROOM3
|
shroom family member 3 |
| chr3_+_153839149 | 1.18 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
| chr19_-_46476791 | 1.17 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
| chr1_-_53387386 | 1.17 |
ENST00000467988.1
ENST00000358358.5 ENST00000371522.4 |
ECHDC2
|
enoyl CoA hydratase domain containing 2 |
| chr3_+_8543561 | 1.15 |
ENST00000397386.3
|
LMCD1
|
LIM and cysteine-rich domains 1 |
| chr14_-_95236551 | 1.15 |
ENST00000238558.3
|
GSC
|
goosecoid homeobox |
| chr3_-_126373929 | 1.14 |
ENST00000523403.1
ENST00000524230.2 |
TXNRD3
|
thioredoxin reductase 3 |
| chr12_-_94673956 | 1.14 |
ENST00000551941.1
|
RP11-1105G2.3
|
Uncharacterized protein |
| chr14_-_90085458 | 1.13 |
ENST00000345097.4
ENST00000555855.1 ENST00000555353.1 |
FOXN3
|
forkhead box N3 |
| chr17_+_1958388 | 1.13 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
| chr2_+_18059906 | 1.11 |
ENST00000304101.4
|
KCNS3
|
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 |
| chr1_-_53387352 | 1.11 |
ENST00000541281.1
|
ECHDC2
|
enoyl CoA hydratase domain containing 2 |
| chr5_+_34656569 | 1.11 |
ENST00000428746.2
|
RAI14
|
retinoic acid induced 14 |
| chr3_+_8543393 | 1.10 |
ENST00000157600.3
ENST00000415597.1 ENST00000535732.1 |
LMCD1
|
LIM and cysteine-rich domains 1 |
| chr2_+_27371866 | 1.08 |
ENST00000296096.5
|
TCF23
|
transcription factor 23 |
| chr12_+_54447637 | 1.08 |
ENST00000609810.1
ENST00000430889.2 |
HOXC4
HOXC4
|
homeobox C4 Homeobox protein Hox-C4 |
| chr13_-_46679144 | 1.04 |
ENST00000181383.4
|
CPB2
|
carboxypeptidase B2 (plasma) |
| chr13_-_46679185 | 1.03 |
ENST00000439329.3
|
CPB2
|
carboxypeptidase B2 (plasma) |
| chr16_-_79804198 | 1.02 |
ENST00000568389.1
|
RP11-345M22.2
|
RP11-345M22.2 |
| chr1_+_61869748 | 1.02 |
ENST00000357977.5
|
NFIA
|
nuclear factor I/A |
| chr6_+_142623758 | 1.02 |
ENST00000541199.1
ENST00000435011.2 |
GPR126
|
G protein-coupled receptor 126 |
| chr11_+_66624527 | 1.01 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
| chr19_+_2977444 | 1.01 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
| chr1_+_43148625 | 1.01 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
| chr8_-_93115445 | 1.01 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr7_+_128399002 | 1.01 |
ENST00000493278.1
|
CALU
|
calumenin |
| chr4_+_100495864 | 1.00 |
ENST00000265517.5
ENST00000422897.2 |
MTTP
|
microsomal triglyceride transfer protein |
| chr1_-_47407111 | 0.99 |
ENST00000371904.4
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
| chrX_-_15619076 | 0.97 |
ENST00000252519.3
|
ACE2
|
angiotensin I converting enzyme 2 |
| chr14_+_21492331 | 0.97 |
ENST00000533984.1
ENST00000532213.2 |
AL161668.5
|
AL161668.5 |
| chr5_-_112630598 | 0.95 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
| chr11_+_118478313 | 0.95 |
ENST00000356063.5
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
| chr3_-_138665969 | 0.95 |
ENST00000330315.3
|
FOXL2
|
forkhead box L2 |
| chr2_+_135596106 | 0.94 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
| chr19_-_39322497 | 0.94 |
ENST00000221418.4
|
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
| chr16_-_79804394 | 0.93 |
ENST00000567993.1
|
RP11-345M22.2
|
RP11-345M22.2 |
| chr13_-_33859819 | 0.92 |
ENST00000336934.5
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
| chr4_+_5712898 | 0.91 |
ENST00000264956.6
ENST00000382674.2 |
EVC
|
Ellis van Creveld syndrome |
| chr7_-_99381798 | 0.90 |
ENST00000415003.1
ENST00000354593.2 |
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
| chr17_-_31204124 | 0.90 |
ENST00000579584.1
ENST00000318217.5 ENST00000583621.1 |
MYO1D
|
myosin ID |
| chr3_-_123123407 | 0.89 |
ENST00000466617.1
|
ADCY5
|
adenylate cyclase 5 |
| chr1_-_47407136 | 0.89 |
ENST00000462347.1
ENST00000371905.1 ENST00000310638.4 |
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
| chr4_-_111119804 | 0.89 |
ENST00000394607.3
ENST00000302274.3 |
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chrX_+_135278908 | 0.88 |
ENST00000539015.1
ENST00000370683.1 |
FHL1
|
four and a half LIM domains 1 |
| chr2_+_242127924 | 0.88 |
ENST00000402530.3
ENST00000274979.8 ENST00000402430.3 |
ANO7
|
anoctamin 7 |
| chr6_-_138866823 | 0.88 |
ENST00000342260.5
|
NHSL1
|
NHS-like 1 |
| chr5_-_158526756 | 0.87 |
ENST00000313708.6
ENST00000517373.1 |
EBF1
|
early B-cell factor 1 |
| chr1_+_47603109 | 0.87 |
ENST00000371890.3
ENST00000294337.3 ENST00000371891.3 |
CYP4A22
|
cytochrome P450, family 4, subfamily A, polypeptide 22 |
| chr1_-_153521714 | 0.87 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
| chr6_+_159590423 | 0.86 |
ENST00000297267.9
ENST00000340366.6 |
FNDC1
|
fibronectin type III domain containing 1 |
| chr16_+_28874860 | 0.86 |
ENST00000545570.1
|
SH2B1
|
SH2B adaptor protein 1 |
| chr9_-_4299874 | 0.86 |
ENST00000381971.3
ENST00000477901.1 |
GLIS3
|
GLIS family zinc finger 3 |
| chr16_-_57520378 | 0.86 |
ENST00000340099.4
|
DOK4
|
docking protein 4 |
| chrX_+_135279179 | 0.86 |
ENST00000370676.3
|
FHL1
|
four and a half LIM domains 1 |
| chr15_+_39873268 | 0.86 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
| chr15_-_52404921 | 0.84 |
ENST00000561198.1
ENST00000260442.3 |
BCL2L10
|
BCL2-like 10 (apoptosis facilitator) |
| chr3_+_157154578 | 0.84 |
ENST00000295927.3
|
PTX3
|
pentraxin 3, long |
| chr9_+_135458021 | 0.82 |
ENST00000542090.1
|
BARHL1
|
BarH-like homeobox 1 |
| chr22_+_46546406 | 0.82 |
ENST00000440343.1
ENST00000415785.1 |
PPARA
|
peroxisome proliferator-activated receptor alpha |
| chr8_+_37654424 | 0.81 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
| chr11_-_64013663 | 0.80 |
ENST00000392210.2
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
| chr2_-_65593784 | 0.80 |
ENST00000443619.2
|
SPRED2
|
sprouty-related, EVH1 domain containing 2 |
| chr5_+_140810132 | 0.80 |
ENST00000252085.3
|
PCDHGA12
|
protocadherin gamma subfamily A, 12 |
| chr8_-_101733794 | 0.78 |
ENST00000523555.1
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1 |
| chr11_-_111783595 | 0.77 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr17_+_4802713 | 0.75 |
ENST00000521575.1
ENST00000381365.3 |
C17orf107
|
chromosome 17 open reading frame 107 |
| chr6_-_138893661 | 0.75 |
ENST00000427025.2
|
NHSL1
|
NHS-like 1 |
| chr6_+_152128810 | 0.75 |
ENST00000406599.1
|
ESR1
|
estrogen receptor 1 |
| chr11_+_4664650 | 0.74 |
ENST00000396952.5
|
OR51E1
|
olfactory receptor, family 51, subfamily E, member 1 |
| chr14_+_21498360 | 0.74 |
ENST00000321760.6
ENST00000460647.2 ENST00000530140.2 ENST00000472458.1 |
TPPP2
|
tubulin polymerization-promoting protein family member 2 |
| chr3_-_100566492 | 0.73 |
ENST00000528490.1
|
ABI3BP
|
ABI family, member 3 (NESH) binding protein |
| chr3_-_171489085 | 0.73 |
ENST00000418087.1
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific |
| chr5_+_3596168 | 0.73 |
ENST00000302006.3
|
IRX1
|
iroquois homeobox 1 |
| chr2_-_220083076 | 0.73 |
ENST00000295750.4
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
| chr4_+_5712942 | 0.73 |
ENST00000509451.1
|
EVC
|
Ellis van Creveld syndrome |
| chr1_+_196857144 | 0.73 |
ENST00000367416.2
ENST00000251424.4 ENST00000367418.2 |
CFHR4
|
complement factor H-related 4 |
| chr3_+_188817891 | 0.72 |
ENST00000412373.1
|
TPRG1
|
tumor protein p63 regulated 1 |
| chrX_+_38420623 | 0.72 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
| chr16_+_83986827 | 0.72 |
ENST00000393306.1
ENST00000565123.1 |
OSGIN1
|
oxidative stress induced growth inhibitor 1 |
| chr2_-_89266286 | 0.71 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
| chr2_-_158732340 | 0.71 |
ENST00000539637.1
ENST00000413751.1 ENST00000434821.1 ENST00000424669.1 |
ACVR1
|
activin A receptor, type I |
| chrX_+_9880412 | 0.69 |
ENST00000418909.2
|
SHROOM2
|
shroom family member 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of NR1I2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 6.6 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.4 | 4.2 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 1.1 | 2.1 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.7 | 6.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.7 | 0.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.7 | 2.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.7 | 5.5 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.7 | 4.7 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.7 | 9.9 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.6 | 4.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.6 | 3.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.6 | 1.7 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.5 | 2.7 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
| 0.5 | 3.2 | GO:0006789 | bilirubin conjugation(GO:0006789) |
| 0.5 | 2.6 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.5 | 1.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.5 | 2.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.5 | 1.5 | GO:2000974 | auditory receptor cell fate determination(GO:0042668) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.5 | 1.4 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.5 | 1.8 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.4 | 1.3 | GO:1903570 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.4 | 0.9 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.4 | 1.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.4 | 2.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 1.1 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.4 | 1.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 | 2.5 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.4 | 1.8 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.4 | 1.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.3 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.3 | 3.8 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
| 0.3 | 0.9 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.3 | 6.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.3 | 0.9 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.3 | 5.2 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.3 | 2.9 | GO:0045959 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.3 | 1.9 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.3 | 1.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 | 1.8 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 1.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.2 | 0.7 | GO:0072086 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
| 0.2 | 0.2 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.2 | 0.7 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.2 | 1.5 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.2 | 3.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 0.6 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 0.6 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 0.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 | 0.6 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.2 | 3.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 | 0.5 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.2 | 6.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 | 2.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 | 2.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 | 2.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.2 | 0.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.2 | 1.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.2 | 3.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 0.6 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.1 | 0.4 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.1 | 0.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.1 | 0.4 | GO:1902356 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.1 | 0.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.1 | 0.4 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 0.1 | 3.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.2 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 | 2.3 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 | 0.3 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 | 1.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 1.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 | 0.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.1 | 0.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 1.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.4 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 | 1.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.1 | 1.2 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 2.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.6 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.1 | 1.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.3 | GO:0039003 | pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 | 1.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 | 2.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.1 | 0.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.1 | 0.5 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 2.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 | 0.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 | 1.2 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 0.9 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 1.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 1.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 | 0.5 | GO:0001878 | response to yeast(GO:0001878) |
| 0.1 | 0.3 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
| 0.1 | 9.2 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.1 | 1.0 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 | 0.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 | 0.3 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.1 | 0.3 | GO:0097501 | stress response to metal ion(GO:0097501) |
| 0.1 | 0.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 | 1.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 1.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 4.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 0.4 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 4.2 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.1 | 0.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.1 | 1.0 | GO:0072189 | ureter development(GO:0072189) |
| 0.0 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.0 | 1.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.0 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.0 | 1.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 | 0.5 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.0 | 0.4 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 0.0 | 0.1 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of terminal mannose on C branch(GO:0036510) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.0 | 0.7 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 | 0.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.0 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.0 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.0 | 0.2 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.0 | 0.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.0 | 0.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.0 | 0.3 | GO:0072719 | copper ion import(GO:0015677) cellular response to cisplatin(GO:0072719) |
| 0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.0 | 1.8 | GO:0032924 | activin receptor signaling pathway(GO:0032924) |
| 0.0 | 2.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.0 | 0.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 0.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.0 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 | 5.3 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 | 0.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.0 | 0.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.0 | 0.2 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.0 | 2.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 0.2 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.0 | 0.3 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.0 | 0.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 | 1.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.1 | GO:2000987 | general adaptation syndrome(GO:0051866) positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.0 | 0.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.0 | 0.3 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.0 | 1.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
| 0.0 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 | 2.5 | GO:0030901 | midbrain development(GO:0030901) |
| 0.0 | 0.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.0 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
| 0.0 | 0.1 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.0 | 0.1 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.0 | 0.2 | GO:0044539 | adiponectin-activated signaling pathway(GO:0033211) long-chain fatty acid import(GO:0044539) |
| 0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.0 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.1 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.0 | 0.1 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 | 0.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 | 0.1 | GO:0071105 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.0 | 0.7 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 0.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 | 0.0 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.0 | 0.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.0 | 1.9 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.0 | 0.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.2 | GO:0016236 | macroautophagy(GO:0016236) |
| 0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 2.8 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.7 | 9.9 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.6 | 1.8 | GO:0043257 | laminin-8 complex(GO:0043257) |
| 0.3 | 1.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.3 | 5.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.3 | 3.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 2.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.2 | 0.5 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.2 | 1.8 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 2.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.2 | 6.7 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.6 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.1 | 2.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 1.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 4.7 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 1.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 0.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 1.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 1.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.1 | 1.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.1 | 2.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.1 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 0.3 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.1 | 13.0 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.0 | 0.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.0 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.0 | 10.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 1.3 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 8.4 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.0 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.1 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.0 | 3.8 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 1.6 | GO:0008305 | integrin complex(GO:0008305) |
| 0.0 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.0 | 4.5 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.0 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 1.8 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.0 | 1.1 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.3 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 1.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 0.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 8.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 0.9 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.1 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 1.3 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.0 | 0.2 | GO:0032059 | bleb(GO:0032059) |
| 0.0 | 2.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 3.7 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.6 | 4.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.5 | 2.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.5 | 1.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.4 | 3.8 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.4 | 3.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.4 | 1.5 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.3 | 1.7 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.3 | 0.9 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.3 | 1.8 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.3 | 2.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.3 | 2.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 0.7 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.2 | 12.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.2 | 3.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 1.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 0.7 | GO:0052852 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.2 | 1.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.2 | 0.6 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.2 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 0.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.2 | 3.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.2 | 0.5 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.2 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.2 | 0.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.2 | 0.9 | GO:0070051 | fibrinogen binding(GO:0070051) collagen V binding(GO:0070052) |
| 0.2 | 5.0 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 0.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 2.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.4 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.1 | 2.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.9 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 1.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.1 | 9.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 2.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.4 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.1 | 2.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 1.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.1 | 2.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 1.4 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 3.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 8.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 2.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.9 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 1.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 1.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.4 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 6.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 0.5 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 1.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 2.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.1 | 4.9 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.0 | 1.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.0 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 1.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.0 | 0.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.0 | 1.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.2 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 1.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.1 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.0 | 4.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.0 | 2.7 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.0 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.0 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 12.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.0 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 0.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.0 | 2.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.0 | 0.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 0.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.0 | 1.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.0 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.0 | 0.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.9 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.0 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.0 | 1.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 1.0 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.0 | 0.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 1.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 3.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 4.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 16.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 9.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 10.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 5.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 4.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 4.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 2.8 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 3.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 4.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 2.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 2.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.0 | 2.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 2.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 1.9 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 5.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 2.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 4.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 5.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 11.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.3 | 9.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.3 | 3.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 3.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 4.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 4.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.2 | 5.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 5.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 14.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 8.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 1.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 10.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 2.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 5.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.1 | 5.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 3.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 2.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.0 | 2.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 1.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.0 | 1.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 1.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 0.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.0 | 0.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.0 | 0.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 1.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 2.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.4 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 0.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 1.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 0.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |